Despite the refusal of a number of European countries from the  AstraZeneca anti-cancer vaccine, Armenia imported the first batch of  this drug

ArmInfo. Despite the refusal of a number of European countries from the Swedish-British anti-cancer vaccine produced by AstraZeneca, Armenia imported the  first batch of the drug in the amount of 24 thousand doses.

According to the Ministry of Health of Armenia, vaccination in the  country will be carried out on a voluntary basis and is intended for  citizens who are at risk, in particular medical staff, citizens over  65 years old, as well as citizens from 16 to 64 years old with  chronic diseases, employees of care centers for the elderly, and  their wards.

Recall that a number of EU countries refused to supply the  AstraZeneca vaccine, or suspended the vaccination process of their  citizens due to the registered consequences. It was reported that  after the injection, the vaccinated citizens developed thromboembolic  complications, in addition, deaths were reported.

In particular, the first to refuse the use of the drug was in  Austria, where after vaccination, one woman died, and another was  diagnosed with a pulmonary embolism. Following Austria, vaccination  was temporarily suspended in Denmark, Norway and Iceland, Estonia,  Lithuania, Luxembourg, Cyprus, Latvia, Italy, etc.  At the same time,  the European Medicines Agency (EMA) said that the drug is effective  and safe in comparison with the theoretical danger.

It should be noted that 190,741 cases of coronavirus infection have  been registered in Armenia since the outbreak of the pandemic, which  is 22.6% of the total number of citizens who passed the test. At the  same time, 172,096 people (90.2%) recovered, 3,476 (1.8%) died.